These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 8973548)

  • 121. The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance.
    Tang-Wai DF; Brossi A; Arnold LD; Gros P
    Biochemistry; 1993 Jun; 32(25):6470-6. PubMed ID: 8100149
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein.
    Sauna ZE; Ambudkar SV
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2515-20. PubMed ID: 10716986
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.
    Safa AR
    Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7187-91. PubMed ID: 2902625
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Characterization of a novel bisacridone and comparison with PSC 833 as a potent and poorly reversible modulator of P-glycoprotein.
    Horton JK; Thimmaiah KN; Altenberg GA; Castro AF; Germain GS; Gowda GK; Houghton PJ
    Mol Pharmacol; 1997 Dec; 52(6):948-57. PubMed ID: 9415704
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Effect of colchicine and heat shock on multidrug resistance gene and P-glycoprotein expression in rat liver.
    Vollrath V; Wielandt AM; Acuña C; Duarte I; Andrade L; Chianale J
    J Hepatol; 1994 Nov; 21(5):754-63. PubMed ID: 7890890
    [TBL] [Abstract][Full Text] [Related]  

  • 126. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.
    Horio M; Gottesman MM; Pastan I
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3580-4. PubMed ID: 3368466
    [TBL] [Abstract][Full Text] [Related]  

  • 127. A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles.
    Bebawy M; Morris MB; Roufogalis BD
    Anal Biochem; 1999 Mar; 268(2):270-7. PubMed ID: 10075817
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Photoaffinity labeling of the organic cation/H+ exchanger in renal brush border membrane vesicles.
    Holohan PD; White KE; Sokol PP; Rebbeor J
    J Biol Chem; 1992 Jul; 267(19):13513-9. PubMed ID: 1352295
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance.
    Zordan-Nudo T; Ling V; Liu Z; Georges E
    Cancer Res; 1993 Dec; 53(24):5994-6000. PubMed ID: 7903200
    [TBL] [Abstract][Full Text] [Related]  

  • 130. The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein.
    Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
    Jpn J Cancer Res; 2000 Feb; 91(2):248-54. PubMed ID: 10761713
    [TBL] [Abstract][Full Text] [Related]  

  • 131. P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid.
    Wolf DC; Horwitz SB
    Int J Cancer; 1992 Aug; 52(1):141-6. PubMed ID: 1354202
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Identification of drug interaction sites in P-glycoprotein.
    Greenberger LM
    Methods Enzymol; 1998; 292():307-17. PubMed ID: 9711563
    [No Abstract]   [Full Text] [Related]  

  • 133. P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site.
    Ferry DR; Russell MA; Cullen MH
    Biochem Biophys Res Commun; 1992 Oct; 188(1):440-5. PubMed ID: 1358068
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism.
    Omote H; Al-Shawi MK
    Biophys J; 2006 Jun; 90(11):4046-59. PubMed ID: 16565061
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells.
    Callaghan R; Riordan JR
    J Biol Chem; 1993 Jul; 268(21):16059-64. PubMed ID: 8101846
    [TBL] [Abstract][Full Text] [Related]  

  • 136. New insights into the drug binding, transport and lipid flippase activities of the p-glycoprotein multidrug transporter.
    Sharom FJ; Lugo MR; Eckford PD
    J Bioenerg Biomembr; 2005 Dec; 37(6):481-7. PubMed ID: 16691487
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro.
    Naoe Y; Inami M; Takagaki S; Matsumoto S; Kawamura I; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
    Jpn J Cancer Res; 1998 Oct; 89(10):1047-54. PubMed ID: 9849584
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein.
    Shapiro AB; Ling V
    Biochem Pharmacol; 1997 Feb; 53(4):587-96. PubMed ID: 9105411
    [TBL] [Abstract][Full Text] [Related]  

  • 139. P-glycoprotein-mediated transcellular transport of MDR-reversing agents.
    Saeki T; Ueda K; Tanigawara Y; Hori R; Komano T
    FEBS Lett; 1993 Jun; 324(1):99-102. PubMed ID: 8099333
    [TBL] [Abstract][Full Text] [Related]  

  • 140. The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface.
    Callaghan R; Berridge G; Ferry DR; Higgins CF
    Biochim Biophys Acta; 1997 Sep; 1328(2):109-24. PubMed ID: 9315609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.